Recently, the expression of TRIM63 by RNA in situ hybridization (RNA-ISH) assay has been proposed as another diagnostic marker for TFE3 and TFEB-rearranged renal cell carcinoma [40] even if an external validation has not been performed so far. This evidence concerns the gene TFEB and renal cell carcinoma.